Treatment of a latent infection of herpes virus

Details Treatment of a latent infection of herpes virus Treatment of a latent infection of herpes virus

1997-04-25

1999-06-29

Reamer, James H.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514934, A61K 3152

Patent

active

059168935

ABSTRACT:
A method for the treatment of latent infection of herpesviruses in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A): ##STR1## or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing.

REFERENCES:
patent: 4355032 (1982-10-01), Verheyden et al.
patent: 4423050 (1983-12-01), Verheyden et al.
patent: 4461757 (1984-07-01), Ogilvie
Boyd et al., Antimicrobial Agents and Chemotherapy, 32(3), pp. 358-363 (1988).
Klein et al., Antimicrobial Agents and Chemotherapy, 27(5), pp. 763-768 (1985).
Klein et al., Antimicrobial Agents and Chemotherapy, 15(5), pp. 723-729 (1979).
Nikkels et al., Drugs, 48(4) pp. 528-548 (1994).
Drugs of the Future, 20(4), pp. 415-417 (1995).
Klein et al., Antimicrobial Agents and Chemotherapy, 24(1), pp. 129-131 (1983).
Field et al., Journal of General Virology, 56(2), pp. 259-265 (1981).
Physicians Gen. Rx., pp. 808-809, 1995.
Drug Facts & Comparisons, pp. 2252-2253, 1990.

Affiliated with

Also associated with

Rating

Treatment of a latent infection of herpes virus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of a latent infection of herpes virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of a latent infection of herpes virus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1375596